Andrew Palmer,Garth Rauscher,Alexa Schoen,Madelyn Burkart,Ashley Dunton,Cherry Au,Ami Dave,Ahmad Nassar,Shaoshi Zhu,Alexander O'Hara,Nusrat Africawala,Amani Erra,Vinod Solipuram,Ivy Abraham,Stephanie B Tsai,Maryam Zia,Melissa L Larson,Damiano Rondelli,Jessica K Altman,Wendy Stock,Irum Khan,Olatoyosi Odenike,Anand Ashwin Patel
{"title":"评估骨髓纤维化患者队列中不同结果的驱动因素和风险分层的适用性。","authors":"Andrew Palmer,Garth Rauscher,Alexa Schoen,Madelyn Burkart,Ashley Dunton,Cherry Au,Ami Dave,Ahmad Nassar,Shaoshi Zhu,Alexander O'Hara,Nusrat Africawala,Amani Erra,Vinod Solipuram,Ivy Abraham,Stephanie B Tsai,Maryam Zia,Melissa L Larson,Damiano Rondelli,Jessica K Altman,Wendy Stock,Irum Khan,Olatoyosi Odenike,Anand Ashwin Patel","doi":"10.1038/s41408-025-01366-x","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":8989,"journal":{"name":"Blood Cancer Journal","volume":"52 1","pages":"158"},"PeriodicalIF":11.6000,"publicationDate":"2025-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Assessing drivers of disparate outcomes and applicability of risk stratification in a cohort of patients with myelofibrosis.\",\"authors\":\"Andrew Palmer,Garth Rauscher,Alexa Schoen,Madelyn Burkart,Ashley Dunton,Cherry Au,Ami Dave,Ahmad Nassar,Shaoshi Zhu,Alexander O'Hara,Nusrat Africawala,Amani Erra,Vinod Solipuram,Ivy Abraham,Stephanie B Tsai,Maryam Zia,Melissa L Larson,Damiano Rondelli,Jessica K Altman,Wendy Stock,Irum Khan,Olatoyosi Odenike,Anand Ashwin Patel\",\"doi\":\"10.1038/s41408-025-01366-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":8989,\"journal\":{\"name\":\"Blood Cancer Journal\",\"volume\":\"52 1\",\"pages\":\"158\"},\"PeriodicalIF\":11.6000,\"publicationDate\":\"2025-10-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Blood Cancer Journal\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41408-025-01366-x\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Cancer Journal","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41408-025-01366-x","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
期刊介绍:
Blood Cancer Journal is dedicated to publishing high-quality articles related to hematologic malignancies and related disorders. The journal welcomes submissions of original research, reviews, guidelines, and letters that are deemed to have a significant impact in the field. While the journal covers a wide range of topics, it particularly focuses on areas such as:
Preclinical studies of new compounds, especially those that provide mechanistic insights
Clinical trials and observations
Reviews related to new drugs and current management of hematologic malignancies
Novel observations related to new mutations, molecular pathways, and tumor genomics
Blood Cancer Journal offers a forum for expedited publication of novel observations regarding new mutations or altered pathways.